Miach Orthopaedics Secures $40 Million Financing
Miach Orthopaedics advises funds will enable ongoing operations and expand the U.S. commercial rollout of the BEAR Implant.
Florida / New York
Ph: 561.316.3330
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Miach Orthopaedics advises funds will enable ongoing operations and expand the U.S. commercial rollout of the BEAR Implant.
Ferronova CEO Stewart Bartlett said raising capital in a challenging environment and winning a CRC-P grant was a credit to the strength of Ferronova’s technology.
Funding will support the company’s rapid, full commercialization of its TEECAD® System. “These significant investments underscore the tremendous confidence in our state-of-the-art solution, experienced team, and the growth trajectory we are on to fully commercialize our TEECAD System,” says Christine Horton, president and CEO of Visura.
Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved
Hours:
M – F 8 am – 5 pm
Florida / New York
Phone: 561.316.3330